JPI Healthcare Co Ltd

JPI Healthcare Co Ltd has a market capitalization of KRW 4,977,765,000,000 and a price-to-earnings ratio of 36.12, indicating a relatively high valuation compared to its earnings. The company reported a net income of KRW 1,378,103,290 in the latest period, with a free cash flow of KRW 1,494,215,010, suggesting it is generating positive cash from operations after capital expenditures. However, the company's operating cash flow was negative at KRW -224,333,140, which may indicate short-term liquidity pressures.

In terms of profitability, JPI Healthcare Co Ltd reported a gross profit of KRW 4,425,017,840 and an operating income of KRW 960,548,620. The company's gross margin is 40.3% and its operating margin is 8.75%, which are key metrics for evaluating performance in the Advanced Medical Equipment & Technology industry. These figures suggest the company is maintaining a healthy margin profile, though a direct comparison to industry medians is not available in the current dataset.

The company's revenue concentration and geographic exposure are not explicitly detailed in the available data. However, as a South Korean firm, it is likely exposed to domestic healthcare demand and regulatory environments, which are significant factors in the industry. The absence of segment-specific revenue data limits the ability to assess diversification or concentration risk in the business.

JPI Healthcare Co Ltd reported revenue of KRW 10,985,483,600 in the latest period, but no growth trajectory or outlook for the current or next fiscal year is provided in the available data. The lack of forward-looking guidance makes it difficult to assess the company's growth potential or strategic direction.

The company's risk profile includes a low dilution potential, with no significant dilution sources identified in the available documents. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. This lack of information may limit the ability to fully evaluate the company's financial health and operational stability.

No recent events, such as filings or transcripts, are available in the provided data to inform the company's current strategic or operational developments. This absence of recent activity may suggest a stable but uneventful period for the company.

JPI Healthcare Co Ltd (0010V0.KQ) has been formally classified within the Healthcare economic sector, specifically operating in Advanced Medical Equipment & Technology. This medium-severity update establishes the company’s primary business activity, providing a clearer framework for understanding its operational focus and market positioning. Alongside this sectoral definition, the company’s risk profile has been updated with new assessments. Dilution risk is now rated as low, indicating a stable capital structure with minimal threat of share value erosion from new issuances. Conversely, liquidity risk remains unknown, suggesting that current data is insufficient to determine the ease with which the company can meet short-term obligations. These changes represent the first tracked-field updates for the entity, shifting key metrics from null values to defined states. The classification of dilution risk as low is a positive signal for existing shareholders, while the unknown liquidity status highlights an area where further financial disclosure or analysis may be needed to fully assess financial health. Currently, JPI Healthcare Co Ltd shows no analyst coverage, index membership, or disclosed top holders, and the officer count is listed as zero. This lack of external market data points underscores the early stage of public tracking for the company, making the newly established sector and risk classifications critical baseline information for investors.